Advertisement

BioNanoScience

, Volume 2, Issue 4, pp 179–184 | Cite as

Bio-nanomechanical Detection of Diabetic Marker HbA1c

  • Priyanka Sharma
  • Adity Chopra
  • Shilpa Chaudhary
  • C. Raman SuriEmail author
Article

Abstract

We report the development of an ultrasensitive immunosensor system for the detection of specific diabetic biomarker glycated hemoglobin (HbA1c) using specific antibody functionalized micromechanical cantilever chips. The biomolecules-induced deflection of the cantilever beam reflects the interplay between the strain energy increase of the cantilever and the free energy reduction of the interaction, providing a unique system for investigating the connection between the nanomechanics and the chemistry of antibody–antigen interaction at very low concentration. Cantilevers were functionalized with specific antibodies using site-directed antibody immobilization technique which was adopted to attach antibody on to the gold substrate. The antibody immobilized cantilevers were used to detect the level of the expressed biomarker in standard samples by adopting direct immunoassay format without using any labels. The assay exhibited an excellent sensitivity for HbA1c in the dynamic range from 0.147 to 1.47 pM. This label-free detection method could be used for fast, high-throughput screening of specific biomarkers for the therapeutic management of diabetes mellitus in clinical diagnostic at a very low cost.

Keywords

Cantilever Flow assembly Antibodies HbA1c 

Notes

Acknowledgments

University Grant Commission India is gratefully acknowledged for the financial support for awarding Senior Research fellowship to PS and AC. Authors greatly acknowledge Dr. G Shekhawat for optical detection measurements and Dr. Gina Mustata for AFM imaging at NUANCE, Northwestern University.

References

  1. 1.
    Iberg, N., & Flückiger, R. (1986). Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites. The Journal of Biological Chemistry, 261, 13542–13545.Google Scholar
  2. 2.
    Abbreviated Report of a WHO Consultation (2011). Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. WHO, Geneva.Google Scholar
  3. 3.
    Du, B. A., Li, Z. P., Liu, C. H. (2006). One-step homogeneous detection of DNA hybridization with gold nanoparticle probes by using a linear light-scattering technique. Angewandte Chemie, International Edition, 45, 8022–8025.CrossRefGoogle Scholar
  4. 4.
    Kokko, T., Kokko, L., Soukka, T., Lovgren, T. (2007). Homogeneous non-competitive bioaffinity assay based on fluorescence resonance energy transfer. Analytica Chimica Acta, 585, 120–125.CrossRefGoogle Scholar
  5. 5.
    Warnick, G. R., Nauck, M., Rifai, N. (2001). Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. Clinical Chemistry, 47, 1579–1596.Google Scholar
  6. 6.
    Weigum, S. E., Floriano, P. N., Christodoulides, N., McDevitt, J. T. (2007). Cell-based sensor for analysis of EGFR biomarker expression in oral cancer. Lab on a Chip, 7, 995–1003.CrossRefGoogle Scholar
  7. 7.
    Xu, X., Georganopoulou, D. G., Hill, H. D., Mirkin, C. A. (2007). Homogeneous detection of nucleic acids based upon the light scattering properties of silver-coated nanoparticle probes. Analytical Chemistry, 79, 6650–6654.CrossRefGoogle Scholar
  8. 8.
    DCCT Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. The New England Journal of Medicine, 329, 977–986.CrossRefGoogle Scholar
  9. 9.
    The DCCT/EDIC Study Research Group. (2005). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. The New England Journal of Medicine, 353, 2643–2653.CrossRefGoogle Scholar
  10. 10.
    UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837–851.CrossRefGoogle Scholar
  11. 11.
    American Diabetes Association. (2010). Diagnosis and classification of diabetes mellitus. Diabetes Care, Suppl 1, S62–S69.CrossRefGoogle Scholar
  12. 12.
    Guntinas, C., Wissiack, R., Bordin, G., Rodrıguez, A. R. (2003). Determination of haemoglobin A(1c) by liquid chromatography using a new cation-exchange column. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 791, 73–83.CrossRefGoogle Scholar
  13. 13.
    Buchmeiser, M. R. (2001). New synthetic ways for the preparation of high performance liquid chromatography supports. Journal of Chromatography. A, 918, 233–266.CrossRefGoogle Scholar
  14. 14.
    Scott, M. G., Hoffman, J. W., Meltzer, V. N., Siegfried, B. A., Chan, K. M. (1984). Effects of azotemia on results of the boronate-agarose affinity and ion-exchange methods for glycated hemoglobin. Clinical Chemistry, 30, 896–898.Google Scholar
  15. 15.
    Menard, L., Dempsey, M. E., Blankstein, L. A., Aleyassine, H., Wacks, M., Soeldner, J. S. (1980). Quantitative determination of glycosylated hemoglobin A1 by agar gel electrophoresis. Clinical Chemistry, 26, 1598–1602.Google Scholar
  16. 16.
    Thienpont, L. M., Uytfanghe, K. V., Leenheer, A. P. (2002). Reference measurement systems in clinical chemistry. Clinica Chimica Acta, 323, 73–87.CrossRefGoogle Scholar
  17. 17.
    Das, J., Aziz, M. A., Yang, H. (2006). A nanocatalyst based assay for proteins: DNA-free ultrasensitive electrochemical detection using catalytic reduction of p-nitro phenyl gold nanoparticle labels. Journal of the American Chemical Society, 128, 16022–16023.CrossRefGoogle Scholar
  18. 18.
    Healy, D. A., Hayes, C. J., Leonard, P., McKenna, L., O’Kennedy, R. (2007). Biosensor developments: application to prostate-specific antigen detection. Trends in Biotechnology, 25, 125–131.CrossRefGoogle Scholar
  19. 19.
    Yu, F., Persson, B., Lofas, S., Knoll, W. (2004). Surface plasmon fluorescence immunoassay of free prostate-specific antigen in human plasma at the femtomolar level. Analytical Chemistry, 76, 6765–6770.CrossRefGoogle Scholar
  20. 20.
    Yanagisawa, K., Makita, Z., Shiroshita, K., Ueda, T., Fusegawa, T., Kuwajima, S., et al. (1998). Specific fluorescence assay for advanced glycation end products in blood and urine of diabetic patients. Metabolism, 47, 1348–1353.CrossRefGoogle Scholar
  21. 21.
    Arntz, Y., Seelig, J. D., Lang, H. P., Zhang, J., Hunziker, P., Ramseyer, J. P., et al. (2003). Label-free protein assay based on a nanomechanical cantilever array. Nanotechnology, 14, 86–90.CrossRefGoogle Scholar
  22. 22.
    Stoney, G. G. (1909). The tension of metallic films deposited by electrolysis. Proceedings of the Royal Society A, 82, 172–175.CrossRefGoogle Scholar
  23. 23.
    Suri, C. R., Kaur, J., Gandhi, S., Shekhawat, G. (2008). Label-free ultra-sensitive detection of atrazine based on nanomechanics. Nanotechnology, 19, 235502–235507.CrossRefGoogle Scholar
  24. 24.
    San Paulo, A., & Garcıa, R. (2000). High-resolution imaging of antibodies by tapping-mode atomic force microscopy: attractive and repulsive tip-sample interaction regimes. Biophysical Journal, 78, 1599–1605.CrossRefGoogle Scholar
  25. 25.
    Zhang, J., Lang, H. P., Huber, F., Bietsch, A., Grange, W., Certa, U., et al. (2006). Rapid and label-free nanomechanical detection of biomarker transcripts in human RNA. Nature Nanotechnology, 1, 214–220.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Priyanka Sharma
    • 1
  • Adity Chopra
    • 1
  • Shilpa Chaudhary
    • 1
  • C. Raman Suri
    • 1
    Email author
  1. 1.Institute for Microbial TechnologyChandigarhIndia

Personalised recommendations